mounjaro to semaglutide conversion chart Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are Switching from Ozempic to Mounjaro:

The pain of pancreatitis is typically more severe and persistent than common gastrointestinal side effects associated with GLP-1 receptor agonists, such as mild nausea or dyspepsia, which tend to be transient and improve over time

[Glutathione] [PMID: 14844945] Laboratory literature summary: [Glutathione]

The goal is to find the sweet spot where meaningful weight loss continues, appetite remains well-managed per semaglutide weight loss protocols , but the pace does not trigger a hair follicle crisis

With liraglutide, nausea tends to spike during each dose escalation step (every week during the 4-week titration) and can recur cyclically

individual results vary